BIO-TECHNE Corp - COMMON STOCK (TECH) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
TECH on Nasdaq
Shares outstanding
152,309,909
Price per share
$58.81
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
158,849,768
Total reported value
$8,835,839,140
% of total 13F portfolios
0.01%
Share change
+399,889
Value change
+$43,067,599
Number of holders
564
Price from insider filings
$58.81
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-TECHNE Corp - COMMON STOCK (TECH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $536,813,355 11,011,556 BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -57% $186,406,005 -$305,816,579 3,350,818 -62% T. Rowe Price Associates, Inc. 30 Sep 2025

As of 30 Sep 2025, 564 institutional investors reported holding 158,849,768 shares of BIO-TECHNE Corp - COMMON STOCK (TECH). This represents 104% of the company’s total 152,309,909 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIO-TECHNE Corp - COMMON STOCK (TECH) together control 65% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 17,932,373 -2.7% 0.01% $997,577,910
BlackRock, Inc. 7.8% 11,887,082 -2.3% 0.01% $661,278,402
MORGAN STANLEY 4.8% 7,237,877 +10% 0.02% $402,643,221
STATE STREET CORP 3.8% 5,753,393 -1.8% 0.01% $320,061,253
WELLINGTON MANAGEMENT GROUP LLP 3.4% 5,115,133 +350% 0.05% $284,554,850
GEODE CAPITAL MANAGEMENT, LLC 3.2% 4,927,178 +21% 0.02% $273,678,698
Invesco Ltd. 2.6% 3,946,028 +7.7% 0.03% $219,517,538
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% 3,350,144 -62% 0.02% $186,370,000
NEUBERGER BERMAN GROUP LLC 2.2% 3,307,116 +32% 0.13% $183,974,851
MAVERICK CAPITAL LTD 2% 3,012,654 2.2% $167,593,942
AMERIPRISE FINANCIAL INC 1.8% 2,815,161 -18% 0.04% $156,607,476
MAIRS & POWER INC 1.8% 2,807,409 +3.4% 1.5% $156,176,151
DF DENT & CO INC 1.8% 2,780,961 +2.1% 2% $154,704,870
MACKENZIE FINANCIAL CORP 1.7% 2,559,590 -2.3% 0.17% $142,389,992
BAMCO INC /NY/ 1.6% 2,496,323 -11% 0.37% $138,870,448
Sumitomo Mitsui Trust Group, Inc. 1.5% 2,355,618 +0.25% 0.08% $131,043,029
RGM Capital, LLC 1.5% 2,300,052 +4.5% 5.4% $127,951,893
Select Equity Group, L.P. 1.5% 2,251,593 -23% 0.54% $125,256,119
AMERICAN CENTURY COMPANIES INC 1.3% 2,037,806 +78% 0.06% $113,363,148
Bank of New York Mellon Corp 1.3% 1,930,042 +0.36% 0.02% $107,368,284
BROWN ADVISORY INC 1.2% 1,865,601 +5.1% 0.14% $103,783,384
MACQUARIE GROUP LTD 1.2% 1,830,994 +1.9% 0.12% $101,858,366
SNYDER CAPITAL MANAGEMENT L P 1.1% 1,719,135 +29% 1.8% $95,635,480
DIMENSIONAL FUND ADVISORS LP 1.1% 1,710,513 +3% 0.02% $95,129,036
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.1% 1,709,662 +76% 0.25% $95,108,497

Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,868,700 $345,469,032 +$141,670,257 $58.81 85
2025 Q3 158,849,768 $8,835,839,140 +$43,067,599 $55.63 564
2025 Q2 158,628,992 $8,162,083,726 -$121,661,653 $51.45 549
2025 Q1 160,406,469 $9,401,176,396 +$178,664,913 $58.63 566
2024 Q4 156,645,630 $11,284,557,145 +$201,642,429 $72.03 564
2024 Q3 152,681,362 $12,198,222,686 -$146,191,369 $79.93 554
2024 Q2 156,002,769 $11,177,152,489 -$58,158,862 $71.65 564
2024 Q1 157,059,318 $11,053,134,526 +$61,380,607 $70.39 545
2023 Q4 3,938,319 $303,881,113 -$11,087,149 $77.16 6
2023 Q3 150,368,159 $10,233,972,367 +$32,498,162 $68.07 516
2023 Q2 149,284,882 $12,180,324,692 +$77,675,360 $81.63 513
2023 Q1 145,979,302 $10,828,014,262 -$105,130,839 $74.19 532
2022 Q4 149,540,844 $12,395,308,685 +$9,089,770,221 $82.88 529
2022 Q3 37,734,695 $10,722,013,305 +$239,762,919 $284.00 510
2022 Q2 37,200,463 $12,883,309,849 -$189,022,229 $346.64 527
2022 Q1 37,695,331 $16,324,488,921 +$325,380,404 $433.04 541
2021 Q4 35,635,129 $18,429,564,644 +$19,368,121 $517.34 551
2021 Q3 35,549,426 $17,226,976,177 +$86,316,491 $484.57 548
2021 Q2 35,446,832 $15,957,416,647 +$195,777,149 $450.26 502
2021 Q1 35,191,922 $13,442,092,997 +$222,059,313 $381.93 455
2020 Q4 34,705,159 $11,023,424,065 -$16,130,576 $317.55 421
2020 Q3 34,949,742 $8,659,462,868 -$30,620,174 $247.73 405
2020 Q2 36,365,292 $9,601,469,846 -$62,475,148 $264.07 381
2020 Q1 36,554,541 $6,936,753,781 +$119,513,742 $189.62 349
2019 Q4 35,762,457 $7,849,865,139 -$45,994,989 $219.51 362
2019 Q3 35,842,890 $7,014,565,896 +$106,469,141 $195.67 327
2019 Q2 34,794,388 $7,253,722,566 +$156,894,633 $208.49 357
2019 Q1 35,528,640 $7,054,238,070 +$14,037,061 $198.55 342
2018 Q4 35,192,943 $5,093,323,037 -$114,209,922 $144.72 312
2018 Q3 35,823,660 $7,310,716,210 +$16,732,287 $204.11 332
2018 Q2 35,996,960 $5,325,614,237 +$129,420,265 $147.95 331
2018 Q1 35,891,552 $5,420,808,522 -$28,756,131 $151.04 324
2017 Q4 36,357,537 $4,710,255,737 -$40,032,578 $129.55 287
2017 Q3 36,811,303 $4,450,008,901 -$55,334,507 $120.89 278
2017 Q2 37,252,767 $4,377,011,640 +$210,977,241 $117.50 269
2017 Q1 36,529,219 $3,713,036,239 +$392,520,811 $101.65 265
2016 Q4 35,943,839 $3,695,987,947 +$12,677,315 $102.83 269
2016 Q3 35,770,562 $3,914,624,202 -$132,045,948 $109.50 276
2016 Q2 36,877,719 $4,158,221,306 -$54,136,743 $112.77 274
2016 Q1 37,388,387 $3,533,659,945 +$22,107,202 $94.52 250
2015 Q4 37,136,290 $3,342,474,330 +$88,887,303 $90.00 254
2015 Q3 36,268,803 $3,353,312,402 -$38,141,274 $92.46 243
2015 Q2 36,319,054 $3,576,201,794 +$15,172,744 $98.47 236
2015 Q1 36,468,159 $3,656,472,883 +$73,770,608 $100.29 242
2014 Q4 36,050,484 $3,331,456,988 +$2,869,117,168 $92.40 252
2014 Q3 4,950,723 $463,140,000 +$463,139,920 $93.55 24